These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [The reaction of the T-immunity system in patients with malignant skin melanoma and stomach cancer to active nonspecific immunotherapy]. Glinkina LS; Bruvere RZh Vopr Onkol; 1992; 38(6):659-66. PubMed ID: 1300766 [TBL] [Abstract][Full Text] [Related]
8. Immunology and cutaneous malignant melanoma. Sober AJ Int J Dermatol; 1976; 15(1):1-18. PubMed ID: 1107238 [No Abstract] [Full Text] [Related]
9. Immune and gene therapy for melanoma, and the immunobiology of melanoma. Smith KJ; Skelton H Int J Dermatol; 1999 Jul; 38(7):490-508. PubMed ID: 10440277 [No Abstract] [Full Text] [Related]
10. Viral oncolysate in the management of malignant melanoma. I. Preparation of the oncolysate and measurement of immunologic responses. Cassel WA; Murray DR; Torbin AH; Olkowski ZL; Moore ME Cancer; 1977 Aug; 40(2):672-9. PubMed ID: 196739 [TBL] [Abstract][Full Text] [Related]
11. Immunology of human malignant melanoma. Lewis MG Ser Haematol; 1972; 5(5):44-65. PubMed ID: 4598040 [No Abstract] [Full Text] [Related]
16. Immunotherapy for human malignant melanoma. Kopf AW South Med J; 1975 Apr; 68(4):495-503. PubMed ID: 1124416 [TBL] [Abstract][Full Text] [Related]
17. Relapse of melanoma after successful adoptive T-cell therapy: escape through inflammation-induced phenotypic melanoma cell plasticity. Somasundaram R; Herlyn M Pigment Cell Melanoma Res; 2013 Jan; 26(1):2-4. PubMed ID: 23387000 [No Abstract] [Full Text] [Related]
18. Immunology and immunotherapy of human-malignant melanoma: historic review and perspectives for the future. Gutterman JU; Mavligit G; Reed R; Richman S; McBride CE; Hersh EM Semin Oncol; 1975 Jun; 2(2):155-74. PubMed ID: 790574 [No Abstract] [Full Text] [Related]
19. [Immunological aspects of melanoma]. Sjögren H Lakartidningen; 1976 Feb; 73(7):528-30. PubMed ID: 1250045 [No Abstract] [Full Text] [Related]
20. [The characterization of tumour-associated membrane-bound antigens and their implementation in the treatment of malignant melanoma (author's transl)]. Kokoschka EM Wien Klin Wochenschr Suppl; 1979; 97():3-32. PubMed ID: 106559 [No Abstract] [Full Text] [Related] [Next] [New Search]